Retrospective Observational Study on GERD Management in General Hospitals in Korea

A RetrospectiVe ObservatIoNal Study of a CurrEnt Status and Its Management of GERD (GastroEsophageal Reflux Disease) in General HOspitals in Korea

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06974903

Acronym

VINCERO

Enrollment

13750

Registered

2025-05-16

Start date

2018-01-03

Completion date

2024-12-31

Last updated

2025-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease (GERD)

Keywords

GastroEsophageal Reflux Disease, GERD, Korean patients, Observational study, RetrospectiVe Observational study

Brief summary

A RetrospectiVe ObservatIoNal Study of a CurrEnt Status and its Management of GERD (GastroEsophageal Reflux Disease) in General HOspitals in Korea

Detailed description

This study is designed as a multicenter, retrospective observational study. After signing a contract with the research institution or investigator, patients who meet the inclusion/exclusion criteria in the study protocol will be enrolled. The registration of patients at each research site will be carried out in order based on the most recent visit date (or GERD diagnosis date) as of January 1, 2018. Data from the study subjects will be collected by reviewing medical records from January 1, 2018, to August 31, 2020. These data will be recorded in the eCRF through interviews, examinations, and tests performed under the investigator's judgment during routine clinical practice within this period.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Inclusion criteria

1. Patients aged 19 years or older as of the date of their first visit. 2. Patients who visited domestic general hospitals (secondary and tertiary healthcare institutions) at least twice between January 1, 2018, and August 31, 2020, for the diagnosis or treatment of GERD.

Exclusion criteria

1. Patients with no GERD treatment information recorded in the medical records, even once. 2. Patients deemed inappropriate for participation by the investigator (e.g., when the overall GERD diagnosis/treatment information is missing from the medical records).

Design outcomes

Primary

Measure	Time frame	Description
Evaluation of Incidence of Adverse events following the administration of GERD treatment medications	From enrollment to 2 years and 7 months after registration	the safety assessment of all adverse events occurring after GERD medication treatment

Countries

South Korea

Outcome results